WO2009090544A3 - Procédé de production d'atorvastatine calcique amorphe - Google Patents

Procédé de production d'atorvastatine calcique amorphe Download PDF

Info

Publication number
WO2009090544A3
WO2009090544A3 PCT/IB2009/000068 IB2009000068W WO2009090544A3 WO 2009090544 A3 WO2009090544 A3 WO 2009090544A3 IB 2009000068 W IB2009000068 W IB 2009000068W WO 2009090544 A3 WO2009090544 A3 WO 2009090544A3
Authority
WO
WIPO (PCT)
Prior art keywords
atorvastatin calcium
amorphous atorvastatin
producing amorphous
producing
calcium
Prior art date
Application number
PCT/IB2009/000068
Other languages
English (en)
Other versions
WO2009090544A2 (fr
Inventor
P. V. Srinivas Rao
Yogendra Kumar Chauhan
Tushar Kumar Srivastava
Purna Chandra Ray
Om Dutt Tyagi
Original Assignee
Matrix Laboratories Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matrix Laboratories Limited filed Critical Matrix Laboratories Limited
Publication of WO2009090544A2 publication Critical patent/WO2009090544A2/fr
Publication of WO2009090544A3 publication Critical patent/WO2009090544A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne un procédé amélioré pour la production d'atorvastatine calcique amorphe ainsi qu'un procédé de conditionnement associé.
PCT/IB2009/000068 2008-01-16 2009-01-15 Procédé de production d'atorvastatine calcique amorphe WO2009090544A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN138/CHE/2008 2008-01-16
IN138CH2008 2008-01-16

Publications (2)

Publication Number Publication Date
WO2009090544A2 WO2009090544A2 (fr) 2009-07-23
WO2009090544A3 true WO2009090544A3 (fr) 2009-11-19

Family

ID=40885714

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2009/000068 WO2009090544A2 (fr) 2008-01-16 2009-01-15 Procédé de production d'atorvastatine calcique amorphe

Country Status (1)

Country Link
WO (1) WO2009090544A2 (fr)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002083638A1 (fr) * 2001-04-11 2002-10-24 Cadila Healthcare Limited Procede de production d'atorvastatine calcique sous forme amorphe
WO2005090301A1 (fr) * 2004-03-17 2005-09-29 Ranbaxy Laboratories Limited Forme cristalline d'hemi-calcium d'atorvastatine
WO2006039441A2 (fr) * 2004-09-30 2006-04-13 Dr. Reddy's Laboratories Ltd. Atorvastatine calcique amorphe

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002083638A1 (fr) * 2001-04-11 2002-10-24 Cadila Healthcare Limited Procede de production d'atorvastatine calcique sous forme amorphe
WO2005090301A1 (fr) * 2004-03-17 2005-09-29 Ranbaxy Laboratories Limited Forme cristalline d'hemi-calcium d'atorvastatine
WO2006039441A2 (fr) * 2004-09-30 2006-04-13 Dr. Reddy's Laboratories Ltd. Atorvastatine calcique amorphe

Also Published As

Publication number Publication date
WO2009090544A2 (fr) 2009-07-23

Similar Documents

Publication Publication Date Title
PL2240316T3 (pl) Sposób i urządzenie do wytwarzania pudeł z zestawu półfabrykatów
PL2259972T3 (pl) Zespół wykrojów z tektur, pudełko i sposób wytwarzania pudełka za pomocą takich wykrojów
EP2081714A4 (fr) Procédé de fabrication de produits de métal amorphe
SI2094910T2 (sl) Postopek proizvodnje papirnega proizvoda
EP2050733A4 (fr) Procédé de purification d'acide hydroxycarboxylique, procédé de production d'ester cyclique et procédé de production de poly(acide hydroxycarboxylique)
ZA201001999B (en) Set of blanks, box and production method
GB0911176D0 (en) Carton, blank and method of packaging
HK1150819A1 (en) Packaging and method of producing same
WO2010021738A3 (fr) Procédé pour la fabrication de collagène doublement réticulé
ZA201101497B (en) Packaging container,blank and method of forming a packaging container
EP1996502A4 (fr) Procédé de production d'un emballage
EP2347758A4 (fr) Procédé d'obtention d'une composition de rosuvastatine calcique et produit obtenu
AU2009232967A8 (en) Agrobacterium-mediated method for producing transformed plant
EP2456545B8 (fr) Procédé de production d'une membrane et membrane ainsi produite
EP2216333A3 (fr) Formes cristallines du dexlansoprazole
EP2326742B8 (fr) Utilisation d'une cible pour le dépôt par évaporation par arc, et procédé de fabrication d'une cible convenant à cette utilisation
ZA201003816B (en) Method for production of calcium compounds
ZA200608632B (en) Process for forming amorphous atorvastatin calcium
WO2009090544A3 (fr) Procédé de production d'atorvastatine calcique amorphe
WO2009147626A3 (fr) Forme amorphe anhydre de imatinib mesylate
IL191919A0 (en) Process for preparing a crystalline form of atorvastatin hemi-calcium
EP2265399A4 (fr) Moule et son procédé de fabrication
EP2178223B8 (fr) Procédé de réception d'un signal et procédé de transmission correspondant
HK1120833A1 (en) A fermentation method for producing clavulanic acid
PL2303709T3 (pl) Karton, półwyrób kartonu i sposób konstruowania kartonu

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09702387

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 09702387

Country of ref document: EP

Kind code of ref document: A2